These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6815597)

  • 1. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LHRH and steroid levels in normal ovulatory women.
    Stone SC; Dickey RP; Kastin AJ; Schally AV
    Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.
    Wang CF; Yen SS
    J Clin Invest; 1975 Jan; 55(1):201-4. PubMed ID: 1088908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in pituitary and ovarian hormones following injection of ultra low dose LH-RH in normal and amenorrhoeic women.
    Newton J; Williams CV
    Acta Eur Fertil; 1975 Dec; 6(4):323-9. PubMed ID: 766551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.
    Vandenberg G; DeVane G; Yen SS
    J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary responsiveness to LHRH and TRH in adolescent girls.
    Lemarchand-Béraud T; Zufferey M; Reymond M; Rey-Stocker I
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):241-54. PubMed ID: 96896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role.
    Dafopoulos K; Kotsovassilis CG; Milingos S; Kallitsaris A; Galazios G; Zintzaras E; Sotiros P; Messinis IE
    Hum Reprod; 2004 Sep; 19(9):1985-92. PubMed ID: 15229199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
    Nakano R; Nishi T
    Obstet Gynecol; 1989 Apr; 73(4):617-21. PubMed ID: 2494622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary response to a new analog of luteinizing hormone releasing factor during the menstrual cycle.
    Nakano R; Takekida H; Kotsuji F; Tojo S
    Obstet Gynecol; 1975 Mar; 45(3):263-6. PubMed ID: 1089930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
    Tirelli A; Cagnacci A; Volpe A
    Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensibility of the hypophysis, the gonads and the thyroid of adolescents before and after the administration of oral contraceptives. A resume.
    Rey-Stocker I; Zufferey MM; Lemarchand MT; Rais M
    Pediatr Ann; 1981 Dec; 10(12):15-20. PubMed ID: 6801609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for pituitary priming to gonadotropin-releasing hormone in relation to luteinizing hormone (LH) secretion prior to the preovulatory LH surge in ewes.
    Crawford JL; McNeilly JR; McNeilly AS
    Biol Reprod; 2004 Jul; 71(1):224-35. PubMed ID: 15031142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Messinis IE
    Hum Reprod; 2009 Apr; 24(4):976-81. PubMed ID: 19095668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.